ArticleThe oncologist2016

Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada.

Ian Cromwell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.